Both in Biotechnology
Fennec Pharmaceuticals vs Surrozen
Over the past year FENC returned +18.8% and SRZN returned +174.3%; their daily moves had a correlation of 0.13.
FENC +18.8% SRZN +174.3%Growth of $1, one year, split-adjusted
| Metric | FENC | SRZN |
|---|---|---|
| Price | $10.80 | $31.98 |
| Market cap | $378.7M | $375.9M |
| Today | −1.37% | +7.89% |
| 1 month | −12.0% | +42.6% |
| 6 months | +87.2% | +16.5% |
| Year to date | +40.3% | +41.5% |
| 1 year | +19.5% | +176.6% |
| Revenue growth (YoY) | +85.2% | +408.6% |
| Gross margin | 96.0% | 100.0% |
| Net margin | 11.0% | 640.8% |
| P/E (TTM) | — | — |
| Price / sales | 6.4× | 32.7× |
| Net cash | $41.2M | $102.0M |
| Dividend yield | — | — |
| Volatility (60d) | 58.5% | 166.5% |
| Short % of float | 2.4% | 53.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).